Dr CK Narayan of Chart Advise has a buy call on Strides Pharma Science Ltd. with a target price of Rs 442. The current market price of Strides Pharma Science Ltd. is Rs 431.7 Time period given by the analyst is Intra Day when Strides Pharma Science Ltd. price can reach the defined target. Dr CK Narayan recommended to keep stoploss at Rs 423. Strides Pharma Science Ltd., incorporated in 1990, is a midcap company with a market cap of Rs 3865.83 crore.
Strides Pharma Science Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 1943.67 Crore to Sales Value (92.12 % of Total Sales), Royalty Income which contributed Rs 86.07 Crore to Sales Value (4.07 % of Total Sales), Export Incentives which contributed Rs 48.69 Crore to Sales Value (2.30 % of Total Sales), Sale of services which contributed Rs 25.01 Crore to Sales Value (1.18 % of Total Sales) and Other Operating Revenue which contributed Rs 6.35 Crore to Sales Value (0.30 % of Total Sales)for the year ending 31-Mar-2017.
For the quarter ended 30-06-2018, the company has reported a Consolidated sales of Rs 663.46 Crore, down -.10 % from last quarter Sales of Rs 664.15 Crore and down -21.18 % from last year same quarter Sales of Rs 841.77 Crore Company has reported net profit after tax of Rs 3.75 Crore in latest quarter. The companys top management includes Mr.Arun Kumar, Mr.Badree Komandur, Mr.Bharat D Shah, Mr.Deepak Vaidya, Mr.Homi Rustam Khusrokhan, Mr.S Sridhar, Ms.Sangita Reddy. Company has BSR & Co. LLP as its auditoRs As on 30-06-2018, the company has a total of 89,548,913 shares outstanding.